Skip to main content

Table 1 Clinico-pathological parameters of all 109 bladder cancer specimens analyzed in this study (RT-PCR/MSP/immunohistochemistry)

From: Epigenetic inactivation of ST6GAL1 in human bladder cancer

  Categorization naanalyzable %
Parameter:    
Age at diagnosis: Median: 69 years   
(range 26–94)
  ≤69 years 55 50.5
  >69 years 54 49.5
Gender    
  Female 29 26.6
  Male 80 73.4
Tumor subtype    
  Carcinoma in situ 13 11.9
  Papillary non-invasive 17 15.6
  Invasive 79 72.5
Histological tumor gradeb   
  G1 14 12.8
  G2 9 8.3
  G3 80 73.4
  unknown 6 5.5
Histological tumor gradec   
  Low grade 15 13.8
  High grade 94 86.2
Tumor stagec    
  pTx 1 0.9
  pTis 13 11.9
  pTa 16 14.7
  pT1 12 11.0
  pT2 25 22.9
  pT3 31 28.4
  pT4 11 10.1
Concomitant CIS    
  Negative 26 23.9
  Positive 52 47.7
  Unknown 31 28.4
Lymph node status    
  Negative 41 37.6
  Positive 18 16.5
  Unknown 50 45.9
  1. aOnly patients with primary bladder cancer were included; baccording to WHO 1973 classification; caccording to WHO 2004 classification.